Insider Transactions in Q2 2021 at Myovant Sciences Ltd. (MYOV)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 28
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,083
-0.86%
|
$73,992
$24.0 P/Share
|
|
May 28
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,300
+0.72%
|
$9,100
$7.78 P/Share
|
|
May 26
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
12,700
-6.66%
|
$304,800
$24.23 P/Share
|
|
May 26
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,700
+6.25%
|
$88,900
$7.78 P/Share
|
|
Apr 15
2021
|
Lauren Merendino Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
78,299
+50.0%
|
-
|
|
Apr 15
2021
|
David C Marek Principal Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
134,789
+27.36%
|
-
|
|
Apr 15
2021
|
Frank Karbe Principal Fin'l & Accounting |
BUY
Grant, award, or other acquisition
|
Direct |
63,138
+22.66%
|
-
|
|
Apr 15
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
51,446
+22.43%
|
-
|
|
Apr 15
2021
|
Matthew Lang General Counsel & Corp. Secy. |
BUY
Grant, award, or other acquisition
|
Direct |
58,461
+23.21%
|
-
|
|
Apr 06
2021
|
Frank Karbe Principal Fin'l & Accounting |
SELL
Open market or private sale
|
Direct |
11,080
-6.78%
|
$199,440
$18.63 P/Share
|
|
Apr 06
2021
|
Matthew Lang General Counsel & Corp. Secy. |
SELL
Open market or private sale
|
Direct |
10,862
-7.45%
|
$195,516
$18.62 P/Share
|
|
Apr 06
2021
|
Ferreira Juan Camilo Arjona Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
8,114
-6.03%
|
$146,052
$18.63 P/Share
|